The present study evaluates the effect of grifolin (GFL) in oxygen/glucose deprivation (OGD) induced white matter lesion. Injury induced with OGD was found to be significant at the 9th h of OGD induction and the effect of GFL on the proliferation of oligodendrocyte precursor cells (OPCs) was assessed by CCK-8 and Hoechst 33258 assay at GFL 1, 5, 25, 50 and 100 µm concentrations. Whereas immunocytochemistry was performed for the assessment of survival and apoptosis of OPCs, western blot assay and RT-PCR were performed after 8th day of OGD injury for the estimation of expressions of myelin basic protein (MBP) and inhibitor of DNA binding 2 (Id2) in OPCs respectively. Results of the study suggests that treatment with GFL significantly enhances the survival rate and decreases the apoptosis of OPCs in OGD induced injury model. Immunocytochemical staining of Oligodendrocyte transcription factor (Olig2) and Bromodeoxyuridine (Brdu) shows that GFL treatment improves the proliferation of OPCs than OGD group. Moreover data of western blot assay suggested that treatment with GFL significantly enhances the expressions of MBP and Olig2 than OGD. It was observed that expressions of Id2 decreases and Olig2 enhances in GFL treated group than OGD group. Data of our study concludes that GFL enhances the differentiation and proliferation of OPCs in OGD-induced injury by altering the expressions of Id2 and Olig2.
Introduction
In the central nervous system, myelin is formed from oligodendrocytes. Survival of axon and conduction of neuron is rapidly facilitated by oligodendrocytes [1] . Oligodendrocytes mature into myelinated ones, during late embryonic development oligodendrocyte precursor cells migrate and proliferate into oligodendrocytes [2] . Hypoxia and premature delivery results in the injury of white matter of the brain that causes mortality and neurological deficits [3] . Presently, a small number of therapies are available that can prevent white matters injury.
Literature suggests that white matter contain oligodendrocyte precursor cells that may help remyelinate the ganglia and thereby repair the injury [4] . Thus it is important to protect the show beneficial effect against cerebral injury in experimental rat model [5, 6] . Grifolin is a phenolic compound isolated from Albatrellus ovinus mushroom [7] . Literature reported that grifolin posse's potent anti-inflammatory and anticancer activity [8, 9] . A study reports that grifolin inhibits the production of nitric oxide (NO) in LPS stimulated RAW 264.7 cells [10] . In addition, it inhibits the release of histamine from mast cell [11] . It was also found to posse's anti atherosclerotic activity and thereby used for the management of cardiovascular disease [12] .
Material and methods

Animals
Female Wistar rats were kept individually under observation for delivery in the cage. 
Discussion
OPCs are developing into the oligodendrocytes at the time of CNS development and later help Hypoxia results in the formation of ROS and thereby damages OPCs [13] . Moreover reported study suggested that OPC injury propagates by accumulation of glutamate and also alters the function of mitochondria in OGD model [14] . GFL shows neuroprotective effect in cerebral ischemia induced rat model as it inhibit the process of apoptosis on the basis of its antioxidant and anti-inflammatory property [15] . Thus present investigation reports neuroprotective effect of grifolin against oxidative stress and neurotoxicity induced by ODG.
Culture of OPCs was found to be grown well after 3days and density of cell was found to be suitable for the further experiment. 
Conclusion
Data of our study concludes that GFL enhances the differentiation and proliferation of OPCs in OGD-induced injury by altering the expressions of Id2 and Olig2. These results show that GFL has a potential to prevent hypoxia related disorders and can be used as a potential therapeutic agent clinically.
